002907 华森制药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0-100.00%15,41421,94325,97513,551
投资性房地产65,342-4.37%68,32871,15718,97023,762
固定资产487,543-7.64%527,896567,397604,288630,462
在建工程9,281-8.93%10,19125,77617,51623,550
无形资产213,31469.45%125,888107,13675,25776,793
商誉0--0000
其他非流动资产133,195-3.82%138,488163,406167,711109,268
908,6742.54%886,205956,815909,717877,386

流动资产
货币资金302,969-33.64%456,553437,565503,529429,968
应收账款207,32618.58%174,843169,364216,844163,579
存货124,094-11.44%140,125151,677114,756127,437
其他流动资产454,63874.98%259,824136,034121,821173,114
1,089,0275.59%1,031,345894,639956,949894,098

流动负债
短期借款0--0000
应付票据0--0000
应付帐款65,6612.02%64,36355,23348,04376,103
其他流动负债167,80713.64%147,671133,445163,277130,867
233,46710.11%212,034188,677211,320206,970
流动资产净值855,5594.42%819,310705,962745,630687,127
资产总额减流动负债1,764,2333.44%1,705,5151,662,7771,655,3471,564,513

非流动负债
长期借款0--0000
应付债券0--000250,917
其他非流动负债54,19619.07%45,51744,85644,95747,676
54,19619.07%45,51744,85644,957298,593

总权益
    实收股本417,5960.00%417,596417,596417,596401,691
    储备项目1,271,1492.31%1,242,4021,200,3251,192,794864,229
股东权益1,688,7461.73%1,659,9981,617,9211,610,3901,265,920
非控股权益21,292--0000